@article {Hariri2020.05.07.20085365, author = {Mahmoud Hariri and Wael Obaid and Hazem Rihawi and Salah Safadi and Mary Ana McGlasson}, title = {THE COVID-19 FORECAST IN NORTHWEST SYRIA: The Imperative of Global Action to Avoid Catastrophe}, elocation-id = {2020.05.07.20085365}, year = {2020}, doi = {10.1101/2020.05.07.20085365}, publisher = {Cold Spring Harbor Laboratory Press}, abstract = {Introduction There is limited research on how the COVD-19 pandemic will affect countries with weakened health systems and particularly those in conflict. Syria{\textquoteright}s protracted conflict has strained its health systems and caused fragmentation. In this study, we focus on northwest (NW) Syria, where recent violence has driven almost one million civilians (of the 4.17 million in the area) from their homes between December 2019 and March 2020. The area is challenged by overcrowding, inadequate WASH, shelter and insufficient healthcare services. Internationally promoted measures (social distancing, self-isolation, quarantine, lockdown) are not impossible. We model outcomes, according to three scenarios, should there be a COVD-19 outbreak. We aim to 1. Predict the numbers of cases, including severe and critical ones, and deaths. 2. Identify critical time points when the health system capacity is overwhelmed due to COVID-19.Methodology Using the WHO COVD-19 Essential Supplies Forecasting Tool (COVID-ESFT) and data from the Health Information System Unit on population and health facility capacity and utilization in northwest Syria, we generate predicted numbers of cases, deaths and health care needs according to three scenarios. Scenario One assumes a medium doubling rate (every 4 days) and a medium clinical attack rate (20\% of the population). Scenario Two assumes a fast doubling rate (every 3.2 days) and a medium clinical attack rate (20\% of the population). Camp-population Scenario assumes a very fast doubling rate (every 2.3 days) and a medium clinical attack rate (20\% of the population). Scenarios One and Two apply to the total population of 4.17 million and for 8 weeks from the first case while Camp-population Scenario applies only to the 1.2 million internally displaced persons (IDPs) in camps and tented settlements and for 6 weeks from the first case. For each scenario, we identify critical time-points when the health system capacity is overwhelmed assuming a highly conservative estimate that 50\% of regular hospital (ward) and ICU beds can be occupied by COVID-19 patients.Results: Scenario One Predicts 16,384 cases (0.4\% of the total population), of which 2,458 are severe and 819 are critical, and 978 deaths in the first 8 weeks. Scenario Two predicts 185,364 cases (4.4\% of the population), of which 27805 are severe and 9268 are critical, and 11,066 deaths in the first 8 weeks. Camp-population Scenario predicts 240,000 cases (20\% of the IDP population) of which 36,000 are severe and 12,000 are critical and 14,328 deaths in the first 6 weeks. With only 2,429 inpatient beds and 240 ICU beds (98 with adult ventilators, 62 with paediatric ventilators) in northwest Syria, ward and ICU bed capacities will be overwhelmed within 4{\textendash}7 weeks. The Camp-population Scenario will see the earliest critical time-points.Conclusion and recommendations Should a COVID-19 outbreak occur in NW Syria, projected cases and deaths will be particularly severe among IDPs. Health system capacity will be overwhelmed within a short period after the first case in camp settings. There is need for further research to account for additional variables that can impact projections. However, it is urgent for international community to mobilize efforts and resources to support community-based measures, increase testing, strengthen health system capacity.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study has not received fundingAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThis study uses WHO ESFT projecting tool to predict estimate of COVID-19 casesThis tool is publicly availableEstimate by study researchers can be made available on request}, URL = {https://www.medrxiv.org/content/early/2020/05/11/2020.05.07.20085365}, eprint = {https://www.medrxiv.org/content/early/2020/05/11/2020.05.07.20085365.full.pdf}, journal = {medRxiv} }